Allergena

Product NDC
62713-100
11-digit product format
627130100
Labeler code
62713
Product ID
62713-100_5befc2d2-a75e-4d8e-e063-6294a90a32d2
Type
HUMAN OTC DRUG
Nonproprietary name
Alternaria Tenuis, Aspergillus Mixture, Botrytis Cinerea, Chaetomium Globosum, Cladosporium Cladosporioides, Curvularia, Epicoccum Nigrum, Fusarium Vasinfectum, Mucor Racemosus, Neurospora, Nigrospora, Penicillium Mixture, Phoma Herbarum, Pullularia Pullulans, Rhizopus, Rhodotorula, Stemphylium, Trichoderma Lignorum, Trichophyton Mentagrophytes, Baptisia Tinctoria, Hydrastis Canadensis, Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Trigonella Foenum-Graecum, Echinacea
Dosage form
LIQUID
Route
ORAL
Labeler
Meditrend, Inc. DBA Progena Professional Formulations
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2025-09-25
Substance
ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOTRYTIS CINEREA; CHAETOMIUM GLOBOSUM; CLADOSPORIUM CLADOSPORIOIDES; COCHLIOBOLUS SPICIFER; EPICOCCUM NIGRUM; FUSARIUM OXYSPORUM VASINFECTUM; MUCOR RACEMOSUS; NEUROSPORA SITOPHILA; KHUSKIA ORYZAE; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PHOMA EXIGUA VAR. EXIGUA; RHIZOPUS STOLONIFER; RHODOTORULA RUBRA; STEMPHYLIUM SARCINIFORME; TRICHODERMA VIRIDE; TRICHOPHYTON MENTAGROPHYTES; BAPTISIA TINCTORIA ROOT; GOLDENSEAL; MYRRH; PHYTOLACCA AMERICANA ROOT; FENUGREEK LEAF; ECHINACEA, UNSPECIFIED
Active strength
30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 3; 3; 3; 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes
Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG...
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Allergena
Brand name suffix
Mold Mix
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ALTERNARIA ALTERNATA30 [hp_X]/mL
ASPERGILLUS NIGER VAR. NIGER30 [hp_X]/mL
AUREOBASIDIUM PULLULANS VAR. PULLUTANS30 [hp_X]/mL
BOTRYTIS CINEREA30 [hp_X]/mL
CHAETOMIUM GLOBOSUM30 [hp_X]/mL
CLADOSPORIUM CLADOSPORIOIDES30 [hp_X]/mL
COCHLIOBOLUS SPICIFER30 [hp_X]/mL
EPICOCCUM NIGRUM30 [hp_X]/mL
FUSARIUM OXYSPORUM VASINFECTUM30 [hp_X]/mL
MUCOR RACEMOSUS30 [hp_X]/mL
NEUROSPORA SITOPHILA30 [hp_X]/mL
KHUSKIA ORYZAE30 [hp_X]/mL
PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM30 [hp_X]/mL
PHOMA EXIGUA VAR. EXIGUA30 [hp_X]/mL
RHIZOPUS STOLONIFER30 [hp_X]/mL
RHODOTORULA RUBRA30 [hp_X]/mL
STEMPHYLIUM SARCINIFORME30 [hp_X]/mL
TRICHODERMA VIRIDE30 [hp_X]/mL
TRICHOPHYTON MENTAGROPHYTES30 [hp_X]/mL
BAPTISIA TINCTORIA ROOT3 [hp_X]/mL
GOLDENSEAL3 [hp_X]/mL
MYRRH3 [hp_X]/mL
PHYTOLACCA AMERICANA ROOT3 [hp_X]/mL
FENUGREEK LEAF3 [hp_X]/mL
ECHINACEA, UNSPECIFIED3 [hp_X]/mL

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
62713-100-016271301000130 mL in 1 BOTTLE, DROPPER (62713-100-01) 30 ml2025-09-25NoNoCurrent
62713-100-026271301000259 mL in 1 BOTTLE, DROPPER (62713-100-02) 59 ml2025-09-25NoNoCurrent